A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea

Scandinavian Journal of Gastroenterology

Volumn 49, Issue 8, 2014, Pages 917-924

  Lee, Jung Won ^a,b   Kim, Nayoung ^a,b   Kim, Jung Mogg ^c   Nam, Ryoung Hee ^a   Kim, Jae Yeon ^b   Lee, Ju Yup ^a   Lee, Dong Ho ^a,b   Jung, Hyun Chae ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

15 day sequential; Eradication; Helicobacter pylori; Resistance

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; ESOMEPRAZOLE; METRONIDAZOLE; ANTIINFECTIVE AGENT; PROTON PUMP INHIBITOR;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ANOREXIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG DOSE SEQUENCE; DRUG EFFICACY; DYSPEPSIA; ERADICATION THERAPY; FEMALE; GASTROESOPHAGEAL REFLUX; HEADACHE; HEARTBURN; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; METALLIC TASTE; MINIMUM INHIBITORY CONCENTRATION; NAUSEA; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOUTH KOREA; TREATMENT DURATION; TREATMENT REFUSAL; UNSPECIFIED SIDE EFFECT; UREA BREATH TEST; VOMITING; AGED; BREATH ANALYSIS; COMPARATIVE STUDY; DRUG ADMINISTRATION; DRUG COMBINATION; FOLLOW UP; HELICOBACTER INFECTIONS; MIDDLE AGED; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BREATH TESTS; CLARITHROMYCIN; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; REPUBLIC OF KOREA; TREATMENT OUTCOME;

EID: 84904428960     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2014.896409     Document Type: Article

References (34)

1. Bruce MG, Maaroos HI. Epidemiology of Helicobacter pylori infection. Helicobacter 2008;13:1-6.
2. Malfertheiner P, Megraud F, OMorain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection-the Maastricht IV/Florence Consensus Report. Gut 2012;61:646-64.
3. Graham DY, Fischbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 2010;59:1143-53.
4. Vakil N. H. pylori treatment: new wine in old bottles? Am J Gastroenterol 2009;104:26-30.
5. Choi HS, Chun HJ, Park SH, Keum B, Seo YS, Kim YS, et al. Comparison of sequential and 7-, 10-, 14-d triple therapy for Helicobacter pylori infection. World J Gastroenterol 2012;18:2377-82.
6. Fischbach L, Evans EL. Meta-analysis: The effect of antibiotic resistance status on the efficacy of triple and quadruple firstline therapies for Helicobacter pylori. Aliment Pharmacol Ther 2007;26:343-57. (Pubitemid 47063149)
7. Lee JW, Kim N, Kim JM, Nam RH, Chang H, Kim JY, et al. Prevalence of primary and secondary antimicrobial resistance of Helicobacter pylori in Korea from 2003 through 2012. Helicobacter 2013;18:206-14.
8. Vaira D, Zullo A, Vakil N, Gatta L, Ricci C, Perna F, et al. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: A randomized trial. Ann Intern Med 2007;146:556-63. (Pubitemid 351650536)
9. Zullo A, De Francesco V, Hassan C, Morini S, Vaira D. The sequential therapy regimen for Helicobacter pylori eradication: A pooled-data analysis. Gut 2007;56:1353-7. (Pubitemid 47517826)
10. Sanchez-Delgado J, Calvet X, Bujanda L, Gisbert JP, Tito L, Castro M. Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice. Am J Gastroenterol 2008;103:2220-3.
11. Tong JL, Ran ZH, Shen J, Xiao SD. Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: A meta-analysis. J Clin Pharm Ther 2009;34:41-53.
12. Gisbert JP, Calvet X, OConnor A, Megraud F, OMorain CA. Sequential therapy for Helicobacter pylori eradication: A critical review. J Clin Gastroenterol 2010;44: 313-25.
13. Gatta L, Vakil N, Leandro G, Di Mario F, Vaira D. Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children. Am J Gastroenterol 2009;104:3069-79; quiz 1080.
14. Park HG, Jung MK, Jung JT, Kwon JG, Kim EY, Seo HE, et al. Randomised clinical trial: A comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naive patients. Aliment Pharmacol Ther 2012;35:56-65.
15. Chung JW, Jung YK, Kim YJ, Kwon KA, Kim JH, Lee JJ, et al. Ten-day sequential versus triple therapy for Helicobacter pylori eradication: A prospective, open-label, randomized trial. J Gastroenterol Hepatol 2012;27:1675-80.
16. Oh HS, Lee DH, Seo JY, Cho YR, Kim N, Jeoung SH, et al. Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: A prospective, randomized study. J Gastroenterol Hepatol 2012;27: 504-9.
17. Graham DY, Fischbach LA. Empiric therapies for Helicobacter pylori infections. CMAJ 2011;183:E506-8.
18. Fischbach LA, Bravo LE, Zarama GR, Bravo JC, Ojha RP, Priest EL, et al. A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing country. Helicobacter 2009;14:100-8.
19. Kang JM, Kim N, Lee DH, Park YS, Kim YR, Kim JS, et al. Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy. Helicobacter 2007;12:623-8. (Pubitemid 350132062)
20. Romano M, Cuomo A, Gravina AG, Miranda A, Iovene MR, Tiso A, et al. Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: A randomised trial. Gut 2010;59: 1465-70.
21. Yoon H, Kim N, Lee BH, Hwang TJ, Lee DH, Park YS, et al. Moxifloxacin-containing triple therapy as second-line treatment for Helicobacter pylori infection: Effect of treatment duration and antibiotic resistance on the eradication rate. Helicobacter 2009;14:77-85.
22. Jeong MH, Chung JW, Lee SJ, Ha M, Jeong SH, Na S, et al. Comparison of rifabutin-and levofloxacin-based third-line rescue therapies for Helicobacter pylori. Korean J Gastroenterol 2012;59:401-6.
23. Choi WH, Park DI, Oh SJ, Baek YH, Hong CH, Hong EJ, et al. Effectiveness of 10 day-sequential therapy for Helicobacter pylori eradication in Korea. Korean J Gastroenterol 2008;51:280-4.
24. Kwon JH, Lee DH, Song BJ, Lee JW, Kim JJ, Park YS, et al. Ten-day sequential therapy as first-line treatment forHelicobacter pylori infection in Korea: A retrospective study. Helicobacter 2010;15:148-53.
25. Kim YS, Kim SJ, Yoon JH, Suk KT, Kim JB, Kim DJ, et al. Randomised clinical trial: The efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea. Aliment Pharmacol Ther 2011;34:1098-105.
26. Graham DY, Rimbara E. Understanding and appreciating sequential therapy for Helicobacter pylori eradication. J Clin Gastroenterol 2011;45:309-13.
27. Rimbara E, Fischbach LA, Graham DY. Optimal therapy for Helicobacter pylori infections. Nat Rev Gastroenterol Hepatol 2011;8:79-88.
28. Murakami K, Fujioka T, Okimoto T, Sato R, Kodama M, Nasu M. Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy. Int J Antimicrob Agents 2002;19:67-70. (Pubitemid 34119073)
29. Zullo A, De Francesco V, Hassan C, Ridola L, Repici A, Bruzzese V, et al. Modified sequential therapy regimens for Helicobacter pylori eradication: A systematic review. Dig Liver Dis 2013;45:18-22.
30. Liou JM, Chen CC, Chen MJ, Chang CY, Fang YJ, Lee JY, et al. Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial. Lancet 2013;381:205-13.
31. Lim JH, Lee DH, Choi C, Lee ST, Kim N, Jeong SH, et al. Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: A randomized pilot study. Helicobacter 2013;18:180-6.
32. Lee BH, Kim N, Hwang TJ, Lee SH, Park YS, Hwang JH, et al. Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: Effect of treatment duration and antibiotic resistance on the eradication rate in Korea. Helicobacter 2010;15:38-45.
33. Kim SG, Jung HK, Lee HL, Jang JY, Lee H, Kim CG, et al. Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition. Korean J Gastroenterol 2013;62:3-26.
34. Kim JY, Kim NY, Kim SJ, Baik GH, Kim GH, Kim JM, et al. Regional difference of antibiotic resistance of Helicobacter pylori strains in Korea. Korean J Gastroenterol 2011;57: 221-9.